Megan M. Tran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Megan M. Tran has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Fatima N. Mirza
Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, USA
5 shared publications - Lauryn Orsillo
Marian Regional Medical Center Family Medicine Residency, Santa Maria, USA
4 shared publications - Guixing Wei
Spatial Structures in the Social Sciences, Population Studies and Training Center, Brown University, Providence, USA
3 shared publications - John Kawaoka
Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, USA
3 shared publications - Oliver Wisco
Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, RI, United States
3 shared publications - Sara Yumeen
Department of Dermatology Yale School of Medicine New Haven CT USA
3 shared publications
Latest Publications
- 12 October 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 516
Safety events at a dermatology practice: a retrospective cross-sectional analysis of safety event reporting trends and barriers
- 12 October 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 516
Safety events at a dermatology practice: a retrospective cross-sectional analysis of safety event reporting trends and barriers
- Open Access
- 2 February 2026
- Published by MDPI AG in International Medical Education
- Vol. 5 (1) , 20
Diversity Messaging and URiM Representation: A Cross-Specialty Analysis of Residency Websites
While the distribution of those underrepresented in medicine (URiM) varies across US medical specialties, it remains unclear whether residency website diversity messaging influences these patterns by specialty and geographic region. This study investigates residency diversity messaging from different specialties and assesses factors that influence URiM recruitment. The 2024 AAMC Report on Residents identified the three specialties with the highest and lowest URiM representation (Integrated Thoracic Surgery, Otolaryngology, Interventional Radiology, Public Health and General Preventive Medicine, Obstetrics and Gynecology (OBGYN), and Family Medicine). Using FREIDA™, all residency programs were reviewed between December 2024 and March 2025. Websites received diversity indicator scores based on the presence of a nondiscrimination statement, a diversity and inclusion message, a program-specific diversity section, a general diversity section, an appointed diversity leadership position(s) or committee(s), URiM rotations or fellowship opportunities, and diversity initiatives. Diversity scores only differed significantly between OBGYN and Family Medicine (p = 0.003). Significant regional differences include South–Midwest (p = 0.014), South–Northeast (p = 0.030), West–Northeast (p = 0.044), and West–South (p < 0.001). Multivariate analysis showed no relationship between diversity criteria and URiM representation, suggesting current messaging that emphasizes diversity may not be associated with URiM resident proportions. Programs in the South had lower diversity scores, indicating geography may influence URiM representation more than website content.
- 2 February 2026
- Published by MDPI AG in International Medical Education
- Vol. 5 (1) , 20
Open AccessDiversity Messaging and URiM Representation: A Cross-Specialty Analysis of Residency Websites
While the distribution of those underrepresented in medicine (URiM) varies across US medical specialties, it remains unclear whether residency website diversity messaging influences these patterns by specialty and geographic region. This study investigates residency diversity messaging from different specialties and assesses factors that influence URiM recruitment. The 2024 AAMC Report on Residents identified the three specialties with the highest and lowest URiM representation (Integrated Thoracic Surgery, Otolaryngology, Interventional Radiology, Public Health and General Preventive Medicine, Obstetrics and Gynecology (OBGYN), and Family Medicine). Using FREIDA™, all residency programs were reviewed between December 2024 and March 2025. Websites received diversity indicator scores based on the presence of a nondiscrimination statement, a diversity and inclusion message, a program-specific diversity section, a general diversity section, an appointed diversity leadership position(s) or committee(s), URiM rotations or fellowship opportunities, and diversity initiatives. Diversity scores only differed significantly between OBGYN and Family Medicine (p = 0.003). Significant regional differences include South–Midwest (p = 0.014), South–Northeast (p = 0.030), West–Northeast (p = 0.044), and West–South (p < 0.001). Multivariate analysis showed no relationship between diversity criteria and URiM representation, suggesting current messaging that emphasizes diversity may not be associated with URiM resident proportions. Programs in the South had lower diversity scores, indicating geography may influence URiM representation more than website content.
- 7 November 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (4) , 876-882
A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region
- 7 November 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (4) , 876-882
A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region
- 11 September 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (5) , 915-917
Delayed onset eruptive keratoacanthomas following immune checkpoint inhibitor therapy
- 11 September 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (5) , 915-917
Delayed onset eruptive keratoacanthomas following immune checkpoint inhibitor therapy
- 5 July 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (6) , 1179-1182
PSTPIP1‐associated myeloid‐related proteinemia inflammatory (PAMI) syndrome: A case report and review of the literature
PSTPIP1‐associated myeloid‐related proteinemia inflammatory (PAMI) syndrome is a rare autoinflammatory disorder often arising in pediatric patients. We present a case of an 18‐year‐old female with a past medical history of growth failure, immunoglobulin A nephropathy, and inflammatory arthritis who presented to a pediatric dermatology clinic with findings of acne, psoriasiform dermatitis, and hidradenitis suppurativa, whose clinical, genetic, and laboratory findings were most consistent with PAMI syndrome. We conducted a literature review to better characterize this rare condition in the context of dermatologic findings. Recognition of the distinctive skin findings seen in PAMI syndrome can help distinguish it from other inflammatory disorders, enabling expedited diagnosis and treatment.
- 5 July 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (6) , 1179-1182
PSTPIP1‐associated myeloid‐related proteinemia inflammatory (PAMI) syndrome: A case report and review of the literature
PSTPIP1‐associated myeloid‐related proteinemia inflammatory (PAMI) syndrome is a rare autoinflammatory disorder often arising in pediatric patients. We present a case of an 18‐year‐old female with a past medical history of growth failure, immunoglobulin A nephropathy, and inflammatory arthritis who presented to a pediatric dermatology clinic with findings of acne, psoriasiform dermatitis, and hidradenitis suppurativa, whose clinical, genetic, and laboratory findings were most consistent with PAMI syndrome. We conducted a literature review to better characterize this rare condition in the context of dermatologic findings. Recognition of the distinctive skin findings seen in PAMI syndrome can help distinguish it from other inflammatory disorders, enabling expedited diagnosis and treatment.
- 31 May 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (6) , 1-4
Tanning beds in unusual locations: the geographic distribution of non-salon tanning facilities across the US
- 31 May 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (6) , 1-4
Tanning beds in unusual locations: the geographic distribution of non-salon tanning facilities across the US
- 20 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (4) , 738-747
Applications and Best Practices for Geospatial Analysis Research in Dermatology
- 20 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (4) , 738-747
Applications and Best Practices for Geospatial Analysis Research in Dermatology
- 15 December 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 17-23
Best Practices for Research in Virtual and Augmented Reality in Dermatology
- 15 December 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 17-23
Best Practices for Research in Virtual and Augmented Reality in Dermatology
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 5954
Abstract 5954: Dietary sugar promotes breast tumorigenesis partially through upregulating 12 lipoxygenase/PPARd signaling and remodeling breast tumor microenvironment
Ample evidence from epidemiological studies links high-sugar diets with increased breast cancer risk, but the underlying molecular mechanisms remain unclear. We previously reported that sucrose-enriched diets (SED) accelerated breast tumorigenesis in MMTV-ErbB2 mice and promoted the breast tumor growth in orthotopic models of mouse (4T1) or human breast cancer cells (MDA-MB-231) by up-regulating 12-lipoxygenase (12-LOX) and its arachidonate metabolite 12-HETE. In this report, we performed mechanistic studies to determine the role of 12-LOX in SED-induced breast tumorigenesis and also examined the SED effects on remodeling breast tumor microenvironment during SED-induced breast tumorigenesis. We found SED (diet with 125 g/kg sucrose), at a concentration equivalent to the average sugar consumption of American population, significantly increased the 4T1 orthotopic tumor weights by 3.7-fold in average compared to the isocaloric cornstarch control diet group. We obtained data showing that 12-LOX downregulation by CRISPR/Cas9 technology not only significantly reduced tumor incidence and inhibited the tumor growth, but also blocked the SED-promoted breast tumor growth in the MDA-MB-231 cell mouse orthotopic model. We also found that SED increased expression of peroxisome proliferator-activated receptor-delta (PPARd), a lipid nuclear receptor along with its target genes (i. g., LPL, CD36 and SCD1) in 4T1 orthotopic breast tumor tissues. 12-LOX downregulation decreased PPARD expression in MDA-MB-231 cells, while 12-HETE increased PPARd and its target proteins such as PDK4 and ANGPLT4 expression levels in 4T1 cells. Together, these data suggest PPARd as a downstream target gene of 12-LOX. Additionally, our studies showed that SED significantly increased chemokine CCL2 in 4T1 orthotopic tumor tissues and 12-HETE led to higher secreted CCL2 in 4T1 mouse breast cancer cells which was blocked by suppressing PPARd expression. Furthermore, we observed 10-fold higher CD11b+/Ly6G+ cells in SED-induced 4T1 tumor tissues by flow cytometry. Among CD45+ cells, percentage of CD8+ T cells was decreased by 34% in SED-induced 4T1 tumors, and percentages of CD8+/CD69+ (active CD8+ T cells) and CD8+/GrzB+ (effector T cells) were reduced by 78% and 60%, respectively, in SED-induced 4T1 tumors, suggesting SED also led to immune suppressive tumor microenvironment (iTME) during breast tumorigenesis. We further noted that MDSCs, but not macrophages, expressed higher CCR2 in TILs of SED fed tumor than that of cornstarch control diet group, indicating SED induced accumulation of MDSCs is likely mediated by CCL2. In conclusion, our data strongly supports added sugar (sucrose) to accelerate the development and progression of breast cancer, potentially involving up-regulation of the expression of 12-LOX and PPARd as well as iTME. Citation Format: Sharmistha Chakraborty, Xiangsheng Zuo, Venkatesh Hedge, Megan Tran, Yan Jiang, Mihai Gagea, Jagannadha Sastry, Peiying Yang. Dietary sugar promotes breast tumorigenesis partially through upregulating 12 lipoxygenase/PPARd signaling and remodeling breast tumor microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5954.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 5954
Open AccessAbstract 5954: Dietary sugar promotes breast tumorigenesis partially through upregulating 12 lipoxygenase/PPARd signaling and remodeling breast tumor microenvironment
Ample evidence from epidemiological studies links high-sugar diets with increased breast cancer risk, but the underlying molecular mechanisms remain unclear. We previously reported that sucrose-enriched diets (SED) accelerated breast tumorigenesis in MMTV-ErbB2 mice and promoted the breast tumor growth in orthotopic models of mouse (4T1) or human breast cancer cells (MDA-MB-231) by up-regulating 12-lipoxygenase (12-LOX) and its arachidonate metabolite 12-HETE. In this report, we performed mechanistic studies to determine the role of 12-LOX in SED-induced breast tumorigenesis and also examined the SED effects on remodeling breast tumor microenvironment during SED-induced breast tumorigenesis. We found SED (diet with 125 g/kg sucrose), at a concentration equivalent to the average sugar consumption of American population, significantly increased the 4T1 orthotopic tumor weights by 3.7-fold in average compared to the isocaloric cornstarch control diet group. We obtained data showing that 12-LOX downregulation by CRISPR/Cas9 technology not only significantly reduced tumor incidence and inhibited the tumor growth, but also blocked the SED-promoted breast tumor growth in the MDA-MB-231 cell mouse orthotopic model. We also found that SED increased expression of peroxisome proliferator-activated receptor-delta (PPARd), a lipid nuclear receptor along with its target genes (i. g., LPL, CD36 and SCD1) in 4T1 orthotopic breast tumor tissues. 12-LOX downregulation decreased PPARD expression in MDA-MB-231 cells, while 12-HETE increased PPARd and its target proteins such as PDK4 and ANGPLT4 expression levels in 4T1 cells. Together, these data suggest PPARd as a downstream target gene of 12-LOX. Additionally, our studies showed that SED significantly increased chemokine CCL2 in 4T1 orthotopic tumor tissues and 12-HETE led to higher secreted CCL2 in 4T1 mouse breast cancer cells which was blocked by suppressing PPARd expression. Furthermore, we observed 10-fold higher CD11b+/Ly6G+ cells in SED-induced 4T1 tumor tissues by flow cytometry. Among CD45+ cells, percentage of CD8+ T cells was decreased by 34% in SED-induced 4T1 tumors, and percentages of CD8+/CD69+ (active CD8+ T cells) and CD8+/GrzB+ (effector T cells) were reduced by 78% and 60%, respectively, in SED-induced 4T1 tumors, suggesting SED also led to immune suppressive tumor microenvironment (iTME) during breast tumorigenesis. We further noted that MDSCs, but not macrophages, expressed higher CCR2 in TILs of SED fed tumor than that of cornstarch control diet group, indicating SED induced accumulation of MDSCs is likely mediated by CCL2. In conclusion, our data strongly supports added sugar (sucrose) to accelerate the development and progression of breast cancer, potentially involving up-regulation of the expression of 12-LOX and PPARd as well as iTME. Citation Format: Sharmistha Chakraborty, Xiangsheng Zuo, Venkatesh Hedge, Megan Tran, Yan Jiang, Mihai Gagea, Jagannadha Sastry, Peiying Yang. Dietary sugar promotes breast tumorigenesis partially through upregulating 12 lipoxygenase/PPARd signaling and remodeling breast tumor microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5954.
- Open Access
- 17 September 2020
- Published by Springer Nature in Cureus
- Vol. 12 (9)
Factors Affecting Patient Decision-Making Regarding Midshaft Clavicle Fracture Treatment
Midshaft clavicle fractures are a common problem encountered by orthopedic surgeons. There remains debate between non-surgical and surgical treatment options for certain midshaft clavicle fractures. Due to the lack of a clear treatment strategy, this presents an opportunity for shared decision-making, which has been shown to be important to patients. A 19-question survey was created encompassing basic demographic information, then taking respondents through a simulation of a midshaft clavicle fracture patient encounter. Subjects were subsequently asked their preferred treatment choice as well as shared decision-making preferences for the simulated encounter. A pilot study was performed with medical students from our home institution to assess study sample size. The survey was then distributed through an online software platform (Amazon Mechanical Turk). Statistical analysis was performed using STATA, Microsoft Excel, and Qualtrics. 253 subjects responded to the online survey. Over 70% of respondents had no to minimal knowledge of clavicle fractures and potential medical interventions/treatments. 67.6% of respondents preferred shared decision-making, over autonomous or paternalistic models. 45.5% of respondents wanted additional time outside the physician-patient consultation before making a treatment decision. A majority of the respondents who selected surgery (44.3%; 43/97) and no surgery (69.9%; 109/156), based their decisions on outcomes data provided in the simulation alone. There was no statistically significant relationship between income, race/ethnicity, education level, work status, sex, or type of visual fracture representation (i.e., radiograph vs. cartoon image) and treatment decision (p>0.05). Younger age (p=0.007) and being married (p=0.001) were associated with increased likelihood to select surgery as the treatment decision. Most respondents had no-to-minimal knowledge about clavicle fractures, placed a high value in shared decision-making for midshaft clavicle fractures, and prioritized outcomes data in making treatment decisions. Younger age and marital status may increase the likelihood of a patient selecting to proceed with surgery over non-operative treatment.
- 17 September 2020
- Published by Springer Nature in Cureus
- Vol. 12 (9)
Open AccessFactors Affecting Patient Decision-Making Regarding Midshaft Clavicle Fracture Treatment
Midshaft clavicle fractures are a common problem encountered by orthopedic surgeons. There remains debate between non-surgical and surgical treatment options for certain midshaft clavicle fractures. Due to the lack of a clear treatment strategy, this presents an opportunity for shared decision-making, which has been shown to be important to patients. A 19-question survey was created encompassing basic demographic information, then taking respondents through a simulation of a midshaft clavicle fracture patient encounter. Subjects were subsequently asked their preferred treatment choice as well as shared decision-making preferences for the simulated encounter. A pilot study was performed with medical students from our home institution to assess study sample size. The survey was then distributed through an online software platform (Amazon Mechanical Turk). Statistical analysis was performed using STATA, Microsoft Excel, and Qualtrics. 253 subjects responded to the online survey. Over 70% of respondents had no to minimal knowledge of clavicle fractures and potential medical interventions/treatments. 67.6% of respondents preferred shared decision-making, over autonomous or paternalistic models. 45.5% of respondents wanted additional time outside the physician-patient consultation before making a treatment decision. A majority of the respondents who selected surgery (44.3%; 43/97) and no surgery (69.9%; 109/156), based their decisions on outcomes data provided in the simulation alone. There was no statistically significant relationship between income, race/ethnicity, education level, work status, sex, or type of visual fracture representation (i.e., radiograph vs. cartoon image) and treatment decision (p>0.05). Younger age (p=0.007) and being married (p=0.001) were associated with increased likelihood to select surgery as the treatment decision. Most respondents had no-to-minimal knowledge about clavicle fractures, placed a high value in shared decision-making for midshaft clavicle fractures, and prioritized outcomes data in making treatment decisions. Younger age and marital status may increase the likelihood of a patient selecting to proceed with surgery over non-operative treatment.